Author: Valentino, Leonard A.; Oza, Veeral M.
Title: Blood safety and the choice of antiâ€hemophilic factor concentrate Cord-id: 08ics9u1 Document date: 2006_5_24
ID: 08ics9u1
Snippet: Hemophilia is a congenital disorder due to the deficiency of the activity of factor VIII (classical hemophilia A) or IX (Christmas disease or hemophilia B). Bleeding is common and may result in longâ€term complications or even death. Bleeding may be treated or prevented by infusion of factor concentrates however these drugs are not without risk. Clinicians often feel ill prepared to provide accurate and impartial information regarding these drugs. This review will provide the reader with an his
Document: Hemophilia is a congenital disorder due to the deficiency of the activity of factor VIII (classical hemophilia A) or IX (Christmas disease or hemophilia B). Bleeding is common and may result in longâ€term complications or even death. Bleeding may be treated or prevented by infusion of factor concentrates however these drugs are not without risk. Clinicians often feel ill prepared to provide accurate and impartial information regarding these drugs. This review will provide the reader with an historical yet up to date perspective on blood safety as it relates to the choice of concentrates to treat hemophilia. Pediatr Blood Cancer 2006;47:245–254. © 2006 Wileyâ€Liss, Inc.
Search related documents:
Co phrase search for related documents- acid testing and liver dysfunction: 1
- acid testing and liver infection: 1
- acid testing and liver infection disease: 1
- acid testing and low prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute bleeding and liver disease: 1, 2, 3, 4, 5
- acute bleeding and liver dysfunction: 1, 2
- acute bleeding and liver transplantation: 1, 2
- adaptive immunity and liver disease: 1, 2, 3, 4
- adaptive immunity and liver infection: 1, 2
- adaptive immunity and low prevalence: 1, 2
Co phrase search for related documents, hyperlinks ordered by date